These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8091675)

  • 1. Exchange of functional domains between Rev proteins of HIV-1 and SIVmac239 results in a dominant negative phenotype.
    Berchtold S; Ries J; Hornung U; Aepinus C
    Virology; 1994 Oct; 204(1):436-41. PubMed ID: 8091675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS; Petrovic A; Jeong KS; Venkatesan S
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay.
    Rizvi TA; Schmidt RD; Lew KA; Keeling ME
    Virology; 1996 Aug; 222(2):457-63. PubMed ID: 8806531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation domain of simian immunodeficiency virus SIVmac239 Rev protein is structurally and functionally analogous to the HIV-1 Rev activation domain.
    Berchtold S; Hornung U; Aepinus C
    Virology; 1995 Aug; 211(1):285-9. PubMed ID: 7645223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence requirements for Rev multimerization in vivo.
    Madore SJ; Tiley LS; Malim MH; Cullen BR
    Virology; 1994 Jul; 202(1):186-94. PubMed ID: 7516596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells.
    Stauber RH; Afonina E; Gulnik S; Erickson J; Pavlakis GN
    Virology; 1998 Nov; 251(1):38-48. PubMed ID: 9813201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General effect of Sam68 on Rev/Rex regulated expression of complex retroviruses.
    Reddy TR; Xu WD; Wong-Staal F
    Oncogene; 2000 Aug; 19(35):4071-4. PubMed ID: 10962565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 by a double transdominant fusion gene.
    Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
    Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perturbation of the carboxy terminus of HIV-1 Rev affects multimerization on the Rev responsive element.
    Daly TJ; Rennert P; Lynch P; Barry JK; Dundas M; Rusche JR; Doten RC; Auer M; Farrington GK
    Biochemistry; 1993 Aug; 32(34):8945-54. PubMed ID: 8364040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
    Modem S; Reddy TR
    J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
    Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
    Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of an additional Sam68 domain for inhibition of human immunodeficiency virus type 1 replication by Sam68 dominant negative mutants lacking the nuclear localization signal.
    Zhang J; Liu Y; Henao J; Rugeles MT; Li J; Chen T; He JJ
    Gene; 2005 Dec; 363():67-76. PubMed ID: 16236470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
    Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
    Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Titration of cellular export factors, but not heteromultimerization, is the molecular mechanism of trans-dominant HTLV-1 rex mutants.
    Heger P; Rosorius O; Hauber J; Stauber RH
    Oncogene; 1999 Jul; 18(28):4080-90. PubMed ID: 10435589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
    Korth MJ; Taylor MD; Katze MG
    Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
    Kubota S; Furuta RA; Hatanaka M; Pomerantz RJ
    Biochem Biophys Res Commun; 1998 Feb; 243(1):79-85. PubMed ID: 9473483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.